Imagine an MRI machine that doesn't require a giant, freezing magnet or a specially shielded room. Instead of a massive tunnel, this is a lightweight, plug-and-play device that works with a tiny fraction of the usual magnetic power. It brings high-tech medical imaging out of specialized hospitals and directly into small clinics or rural areas.
Standard MRI scanners are too expensive and bulky for most clinics, requiring specialized shielded rooms and massive energy consumption. This creates a diagnostic bottleneck and limits healthcare access in rural or low-resource areas.
A functional prototype scanner with a SQUID-based detection chain. It has successfully captured initial biological images of anatomical structures.
If you are a rural clinic dealing with the prohibitive cost of MRI infrastructure — this project developed a plug-and-play scanner that operates at 100-1000x lower field strength. This allows you to provide advanced diagnostics without expensive facility renovations.
If you are a distributor dealing with the difficulty of shipping massive scanners to developing regions — this project developed a lightweight, ultra-low-field system. This enables the sale of diagnostic tools to underserved populations where traditional MRI is impossible to install.
If you are a clinic dealing with patients who cannot use traditional MRIs due to contraindications — this project developed an open-design scanner. This expands your patient base by offering a safe and comfortable alternative for those unable to enter standard tubes.
The project data does not provide a final unit price, but it specifies the goal is to create an affordable system by eliminating costly superconducting magnets.
The company is seeking a €15M EIC Accelerator investment to complete development, regulatory approvals, and market launch between 2024-2027.
The project is based on CHIPIRON's proprietary SQUID-based detection system and proprietary IP already assembled by the team.
Based on available project data, the company is planning to use the 2024-2027 period to move through regulatory approvals before market launch.
The project aims for market launch over the 2024-2027 period following the completion of development and regulatory steps.
The project is led by a single French SME, CHIPIRON. This lean structure indicates a high level of internal control over the proprietary IP and a direct path from development to commercialization, though it lacks diverse academic or industrial partners within the consortium.
Contact CHIPIRON in France regarding their SQUID-based MRI technology.
Contact us to explore licensing or investment opportunities in ultra-low-field imaging.
